CRYOPORT, INC. Goodwill, Gross
CRYOPORT, INC. (CYRX) had Goodwill, Gross of $126.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Goodwill and Other › Goodwill, Impaired, Accumulated Impairment Loss
us-gaap:GoodwillGross · last filed 2026-08-06
- 2026-06-30: Goodwill, Gross $126.20M.
- 2026-03-31: Goodwill, Gross $126.27M.
- 2025-12-31: Goodwill, Gross $126.53M.
- 2025-09-30: Goodwill, Gross $126.54M.
| Period end | Goodwill, Gross | Goodwill, Gross as first filed |
|---|---|---|
| 2026-06-30 | $126.20M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $126.27M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $126.53M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $126.54M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $122.84M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $125.09M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $124.70M 10-Q · filed 2026-08-06 | $155.79M 10-K · filed 2025-03-07 |
| 2024-09-30 | $158.19M 10-Q · filed 2024-11-07 | |
| 2023-12-31 | $125.96M 10-K · filed 2026-03-05 | $157.97M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $151.12M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |